AI in Health: The Voice of Aviva Lev-Ari, PhD, RN linkedin.com/pulse/ai-healt… Aviva Lev-Ari Stephen J Williams @pharma_BI

The Methodology of Curation for Scientific Research Findings pharmaceuticalintelligence.com/2014/07/30/the… via @pharma_BI Aviva Lev-Ari Stephen J Williams

HBS Podcast Roundup: December 2025 linkedin.com/pulse/hbs-podc…

Check out my latest article: NEW Foundation Multimodal Model in Healthcare: LPBI Group’s Domain-aware Corpus for 2025 Grok 4.1 Causal Reasoning & Novel Biomedical Relationships linkedin.com/pulse/new-foun… via LinkedIn Grok Aviva Lev-Ari @pharma_BI Stephen J Williams

Aviva Lev-Ari, PhD, RN - Biography ->> Grokepedia Entry pharmaceuticalintelligence.com/2026/01/11/avi… via @pharma_BI Aviva Lev-Ari Stephen J Williams

Evolving LPBI Group's Portfolio of Intellectual Properties (IP): From 2021 Vision to 2026 Reality pharmaceuticalintelligence.com/2026/01/12/evo… via @pharma_BI Aviva Lev-Ari Stephen J Williams

Evolving LPBI Group's Portfolio of Intellectual Properties (IP): From 2021 Vision to 2026 Reality pharmaceuticalintelligence.com/2026/01/12/evo… via @pharma_BI Aviva Lev-Ari Stephen J Williams

In a statement, American College of Cardiology President Christopher M. Kramer, MD, said, “We welcome the inclusion of several important science-based recommendations, including a focus on eating whole fruits and vegetables, limiting added sugars, highly processed foods,

“Protein and healthy fats are essential and were wrongly discouraged in prior dietary guidelines,” said Department of Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr, at the briefing. “We are ending the war on saturated fats.”

Knowledge Graphs (KG) are used in our Journal Ontology PharmaceuticalIntelligence.com

Cancer Signaling Pathways and Tumor Progression: Images of Biological Processes in the Voice of a Pathologist Cancer Expert pharmaceuticalintelligence.com/2015/06/09/can… via @pharma_BI Aviva Lev-Ari Stephen J Williams Grok

Results of the first Data Set -->>> 2026 Grok Multimodal Causal Reasoning on Proprietary Cariovascular Corpus: From 2021 Wolfram NLP Baseline to Thousands of Novel Relationships – A Second Head-to-Head Validation of LPBI’s Domain-Aware Training Advantage pharmaceuticalintelligence.com/2026/01/06/202…

List of Medical, Pharmaceutical and BioTech Conferences Covered by Aviva Lev-Ari, PhD, RN, 2013 to Present: Total of 77 Conferences in Real Time and virtual pharmaceuticalintelligence.com/press-coverage… via @pharma_BI Aviva Lev-Ari Stephen J Williams Grok

List of Medical, Pharmaceutical and BioTech Conferences Covered by Stephen J. Williams, PhD, 2015 to Present: Total of 23 Conferences in Biotech, Medical, Pharmaceutical and in Life Sciences covered in Real RIme and virtually and Total Views ~3,500 pharmaceuticalintelligence.com/press-coverage… via

2026 World Economic Forum, 1/19 - 1/23/2026, Davos, Switzerland, LPBI Group's KOLs interpretation of AI in Health Videos pharmaceuticalintelligence.com/2026/01/24/202… via @pharma_BI Aviva Lev-Ari Grok

Editorials & Publications of Articles in e-Books by Leaders in Pharmaceutical Business Intelligence (LPBI) Group: Contributions by Aviva Lev-Ari, PhD, RN pharmaceuticalintelligence.com/founder/editor… via @pharma_BI Aviva Lev-Ari Stephen J Williams

Heart Failure and Atrial Fibrilation are two cardiovascular conditions causing increase of negative outcome are associated with Higher BMI which indicates Obesity

Valuation Models per Ten Digital IP Asset Classes in LPBI Group's Portfolio of IP pharmaceuticalintelligence.com/2025/12/08/val… via @pharma_BI Aviva Lev-Ari @StephenJWilllia2 Grok

The Cough That Broke 12 LLMs open.substack.com/pub/sergeiai/p… This is an important study of AI in Healthcare. We @pharma_BI Aviva Lev-Ari Grok will conduct a study on our Respiratory repository and use a different approach. Our study was inspired by this study. Publication, forthcoming

6. Portfolio of IP Assets pharmaceuticalintelligence.com/2026-beyond-ma… via @pharma_BI Aviva Lev-Ari Stephen J Williams I wanted to share the **2026 & Beyond Master Plan** for LPBI Group — a 9 GB private multimodal corpus + proprietary COM Tool Factory designed specifically for AI in drug discovery and